Kuros Biosciences AG (KURN) — Cash Flow Quality Index
Kuros Biosciences AG (KURN) has a Cash Flow Quality Index of 0.54x as of December 2025. Operating cash flow of CHF1.94 Million is below net income of CHF3.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Kuros Biosciences AG to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kuros Biosciences AG Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Kuros Biosciences AG across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Kuros Biosciences AG generate cash.
Annual Cash Flow Quality Index for Kuros Biosciences AG (2015–2025)
Year-by-year earnings quality comparison for Kuros Biosciences AG.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | CHF-377.87K | CHF5.10 Million | ▲ +81.7% |
| 2015 | -0.40x | CHF-2.51 Million | CHF6.23 Million | — |